NYSE · CIK 0001100682
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Insider trading from SEC Form 4. Last filing 5 d ago. Close $301.79 on Oct 9, 2026, +101% from the 52-week low and -3% from the high.
Last 90 days
Net insider value
-$300k
more sold than bought
Buys
1
$2,974 by 1 insider
Sells
1
$303k by 1 insider
Insiders on file
21
with a Form 4 at this company
Price and insider trades, last year
CRLOct 9, 2026 · close 301.79
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Shannon M Parisotto CEVP, Disc & Safety Assessment sell | $303k 981 shares | -17% | +107% from low0% from high | |
| 17Weak | Glenn Coleman EVP & Chief Financial Officer buy | $2,974 10 shares | +0% | +97% from low-1% from high | |
| 26Weak | Joseph W LaPlume EVP, Corp Strategy & Develop sell | $126k 800 shares | -3% | +57% from low-29% from high | |
| 22Weak | Joseph W LaPlume EVP, Corp Strategy & Develop sell | $60k 400 shares | -2% | +50% from low-32% from high | |
| 3Weak | George Massaro director sell | $19k 140 shares | -2% | +39% from low-37% from high | |
| 31Weak | Joseph W LaPlume EVP, Corp Strategy & Develop sell | $73k 500 shares | -2% | +44% from low-35% from high | |
| 3Weak | George Massaro director sell | $20k 140 shares | -2% | +39% from low-37% from high | |
| 41Moderate | Joseph W LaPlume EVP, Corp Strategy & Develop sell | $715k 4,400 shares | -18% | - | |
| 41Moderate | Birgit Girshick Corporate Executive VP & COO buy | $249k 1,514 shares | +3% | - | |
| 58Moderate | James C Foster Chairman, President and CEO buy | $1.0M 6,075 shares | +3% | - | |
| 50Moderate | Richard F Wallman director sell | $1.6M 7,621 shares | -40% | - |
Congressional trades
5 trades in CRL disclosed by members of Congress under the STOCK Act. All congressional trades.
- Jefferson ShreveHouse · R-IN · last Jun 22, 20251 bought
1 sold - Robert P. Bresnahan, Jr.House · R-PA · last May 31, 20251 bought
1 sold - Julie JohnsonHouse · D-TX · last Feb 12, 20251 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Jefferson Shreve House · R-IN | Sale | CRL Charles River Laboratories International, Inc. Common Stock | $15k to $50k | May 12, 2025 / Jun 22, 2025 41 days after the trade | Clerk |
Jefferson Shreve House · R-IN | Purchase | CRL Charles River Laboratories International, Inc. Common Stock | $15k to $50k | May 8, 2025 / Jun 22, 2025 45 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Sale | CRL Charles River Laboratories International, Inc. Common Stock | $1,001 to $15k | May 15, 2025 / May 31, 2025 16 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Purchase | CRL Charles River Laboratories International, Inc. Common Stock | $15k to $50k | Apr 8, 2025 / May 8, 2025 30 days after the trade | Clerk |
Julie Johnson House · D-TX | Purchase | CRL Charles River Laboratories International, Inc. Common Stock | $1,001 to $15k | Jan 15, 2025 / Feb 12, 2025 28 days after the trade | Clerk |
Transactions
The last 96 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Shannon M Parisotto CEVP, Disc & Safety Assessment | MOption exercise Common Stock10b5-1 | +981 | $208.44 | $204k | 5,788 | 5 d ago |
| Oct 5, 2026 | Shannon M Parisotto CEVP, Disc & Safety Assessment | SOpen-market sale Common Stock10b5-1 | -981 | $308.44 | $303k | 4,807 | 5 d ago |
| Oct 5, 2026 | Shannon M Parisotto CEVP, Disc & Safety Assessment | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -981 | $0.00 | $0 | 2,944 | 5 d ago |
| Sep 30, 2026 | Glenn Coleman EVP & Chief Financial Officer | POpen-market purchase Common Stock | +10 | $297.43 | $2,974 | 27,762 | 10 d ago |
| Aug 18, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | SOpen-market sale Common Stock | -800 | $157.60 | $126k | 24,116 | Aug 20, 2025 |
| Aug 7, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | SOpen-market sale Common Stock | -400 | $150.04 | $60k | 24,916 | Aug 8, 2025 |
| Jun 5, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | GGift Common Stock | -385 | $0.00 | $0 | 25,316 | Jun 9, 2025 |
| Jun 2, 2025 | Steven Barg director | AGrant or award Common Stock | +481 | $135.04 | $65k | 481 | Jun 4, 2025 |
| Jun 2, 2025 | Paul W Graves director | AGrant or award Common Stock | +946 | $135.04 | $128k | 946 | Jun 4, 2025 |
| Jun 2, 2025 | Abraham Ceesay director | AGrant or award Common Stock | +946 | $135.04 | $128k | 946 | Jun 4, 2025 |
| Jun 2, 2025 | Mark J Enyedy director | AGrant or award Common Stock | +946 | $135.04 | $128k | 946 | Jun 4, 2025 |
| Jun 2, 2025 | Paul W Graves director | AGrant or award Stock Options (Right to Buy)derivative | +2,082 | $135.04 | $281k | 2,082 | Jun 4, 2025 |
| Jun 2, 2025 | Abraham Ceesay director | AGrant or award Stock Options (Right to Buy)derivative | +2,082 | $135.04 | $281k | 2,082 | Jun 4, 2025 |
| Jun 2, 2025 | Mark J Enyedy director | AGrant or award Stock Options (Right to Buy)derivative | +2,082 | $135.04 | $281k | 2,082 | Jun 4, 2025 |
| Jun 2, 2025 | Steven Barg director | AGrant or award Common Stock | +946 | $135.04 | $128k | 1,427 | Jun 4, 2025 |
| Jun 2, 2025 | Steven Barg director | AGrant or award Stock Options (Right to Buy)derivative | +2,082 | $135.04 | $281k | 2,082 | Jun 4, 2025 |
| May 30, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | AGrant or award Common Stock | +5,603 | $135.63 | $760k | 13,102 | Jun 3, 2025 |
| May 30, 2025 | Flavia Pease Corporate Executive VP & CFO | AGrant or award Common Stock | +7,152 | $135.63 | $970k | 17,482 | Jun 3, 2025 |
| May 30, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | AGrant or award Common Stock | +6,709 | $135.63 | $910k | 25,856 | Jun 3, 2025 |
| May 30, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | AGrant or award Common Stock | +2,064 | $135.63 | $280k | 10,807 | Jun 3, 2025 |
| May 30, 2025 | Birgit Girshick Corporate Executive VP & COO | AGrant or award Common Stock | +12,239 | $135.63 | $1.7M | 66,227 | Jun 3, 2025 |
| May 30, 2025 | Victoria L Creamer EVP & Chief People Officer | AGrant or award Common Stock | +6,252 | $135.63 | $848k | 22,482 | Jun 3, 2025 |
| May 30, 2025 | James C Foster Chairman, President and CEO | AGrant or award Common Stock | +17,253 | $135.63 | $2.3M | 210,685 | Jun 3, 2025 |
| May 31, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | FTax withholding Common Stock | -105 | $135.63 | $14k | 12,997 | Jun 3, 2025 |
| May 31, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | FTax withholding Common Stock | -155 | $135.63 | $21k | 25,701 | Jun 3, 2025 |
| May 31, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -48 | $135.63 | $6,510 | 10,759 | Jun 3, 2025 |
| May 31, 2025 | Birgit Girshick Corporate Executive VP & COO | FTax withholding Common Stock | -283 | $135.63 | $38k | 65,944 | Jun 3, 2025 |
| May 31, 2025 | Victoria L Creamer EVP & Chief People Officer | FTax withholding Common Stock | -120 | $135.63 | $16k | 22,362 | Jun 3, 2025 |
| May 31, 2025 | Flavia Pease Corporate Executive VP & CFO | FTax withholding Common Stock | -185 | $135.63 | $25k | 17,297 | Jun 3, 2025 |
| Jun 1, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -225 | $135.63 | $31k | 10,534 | Jun 3, 2025 |
| May 26, 2025 | Flavia Pease Corporate Executive VP & CFO | FTax withholding Common Stock | -190 | $136.73 | $26k | 10,471 | May 29, 2025 |
| May 26, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | FTax withholding Common Stock | -104 | $136.73 | $14k | 7,608 | May 29, 2025 |
| May 26, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | FTax withholding Common Stock | -161 | $136.73 | $22k | 19,352 | May 29, 2025 |
| May 26, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -50 | $136.73 | $6,837 | 8,805 | May 29, 2025 |
| May 26, 2025 | Birgit Girshick Corporate Executive VP & COO | FTax withholding Common Stock | -281 | $136.73 | $38k | 54,347 | May 29, 2025 |
| May 26, 2025 | Victoria L Creamer EVP & Chief People Officer | FTax withholding Common Stock | -123 | $136.73 | $17k | 16,383 | May 29, 2025 |
| May 27, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | FTax withholding Common Stock | -65 | $136.73 | $8,887 | 7,543 | May 29, 2025 |
| May 27, 2025 | Flavia Pease Corporate Executive VP & CFO | FTax withholding Common Stock | -141 | $136.73 | $19k | 10,330 | May 29, 2025 |
| May 27, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -37 | $136.73 | $5,059 | 8,768 | May 29, 2025 |
| May 27, 2025 | Birgit Girshick Corporate Executive VP & COO | FTax withholding Common Stock | -242 | $136.73 | $33k | 54,105 | May 29, 2025 |
| May 27, 2025 | Victoria L Creamer EVP & Chief People Officer | FTax withholding Common Stock | -91 | $136.73 | $12k | 16,292 | May 29, 2025 |
| May 27, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | FTax withholding Common Stock | -122 | $136.73 | $17k | 19,230 | May 29, 2025 |
| May 28, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | FTax withholding Common Stock | -44 | $138.65 | $6,101 | 7,499 | May 29, 2025 |
| May 28, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | FTax withholding Common Stock | -83 | $138.65 | $12k | 19,147 | May 29, 2025 |
| May 28, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -25 | $138.65 | $3,466 | 8,743 | May 29, 2025 |
| May 28, 2025 | Birgit Girshick Corporate Executive VP & COO | FTax withholding Common Stock | -117 | $138.65 | $16k | 53,988 | May 29, 2025 |
| May 28, 2025 | Victoria L Creamer EVP & Chief People Officer | FTax withholding Common Stock | -62 | $138.65 | $8,596 | 16,230 | May 29, 2025 |
| May 21, 2025 | George Llado Sr. director | AGrant or award Common Stock | +946 | $134.98 | $128k | 4,295 | May 23, 2025 |
| May 21, 2025 | Martin Mackay director | AGrant or award Common Stock | +946 | $134.98 | $128k | 13,477 | May 23, 2025 |
| May 21, 2025 | Craig B. Thompson director | AGrant or award Common Stock | +946 | $134.98 | $128k | 2,413 | May 23, 2025 |
| May 21, 2025 | Reshema Kemps-Polanco director | AGrant or award Common Stock | +946 | $134.98 | $128k | 1,960 | May 23, 2025 |
| May 21, 2025 | Virginia M Wilson director | AGrant or award Common Stock | +946 | $134.98 | $128k | 4,911 | May 23, 2025 |
| May 21, 2025 | Nancy C Andrews director | AGrant or award Common Stock | +946 | $134.98 | $128k | 3,964 | May 23, 2025 |
| May 21, 2025 | Craig B. Thompson director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 21, 2025 | George Llado Sr. director | AGrant or award Common Stock | +519 | $134.98 | $70k | 4,814 | May 23, 2025 |
| May 21, 2025 | Nancy C Andrews director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 21, 2025 | Martin Mackay director | AGrant or award Common Stock | +815 | $134.98 | $110k | 14,292 | May 23, 2025 |
| May 21, 2025 | Reshema Kemps-Polanco director | AGrant or award Common Stock | +630 | $134.98 | $85k | 2,590 | May 23, 2025 |
| May 21, 2025 | Virginia M Wilson director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 21, 2025 | Reshema Kemps-Polanco director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 21, 2025 | George Llado Sr. director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 21, 2025 | Martin Mackay director | AGrant or award Stock Options (Right to Buy)derivative | +2,076 | $134.98 | $280k | 2,076 | May 23, 2025 |
| May 15, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -35 | $136.32 | $4,771 | 5,680 | May 16, 2025 |
| May 15, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -81 | $137.68 | $11k | 5,599 | May 16, 2025 |
| May 15, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -24 | $139.05 | $3,337 | 5,575 | May 16, 2025 |
| May 14, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -91 | $139.95 | $13k | 5,764 | May 15, 2025 |
| May 13, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | SOpen-market sale Common Stock | -500 | $145.41 | $73k | 19,513 | May 15, 2025 |
| May 14, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -21 | $140.78 | $2,956 | 5,743 | May 15, 2025 |
| May 14, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -14 | $141.85 | $1,986 | 5,729 | May 15, 2025 |
| May 14, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -7 | $143.77 | $1,006 | 5,722 | May 15, 2025 |
| May 14, 2025 | George Massaro director | SOpen-market sale Common Stock10b5-1 | -7 | $145.54 | $1,019 | 5,715 | May 15, 2025 |
| May 2, 2025 | Flavia Pease Corporate Executive VP & CFO | FTax withholding Common Stock | -889 | $116.89 | $104k | 10,661 | May 5, 2025 |
| Feb 25, 2025 | Birgit Girshick Corporate Executive VP & COO | GGift Common Stock | -430 | $0.00 | $0 | 54,628 | Feb 26, 2025 |
| Feb 20, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | SOpen-market sale Common Stock | -4,400 | $162.50 | $715k | 20,013 | Feb 21, 2025 |
| Feb 20, 2025 | Birgit Girshick Corporate Executive VP & COO | POpen-market purchase Common Stock | +1,514 | $164.63 | $249k | 55,058 | Feb 21, 2025 |
| Feb 20, 2025 | James C Foster Chairman, President and CEO | POpen-market purchase Common Stock | +6,075 | $165.01 | $1.0M | 183,639 | Feb 21, 2025 |
| Jan 31, 2025 | Birgit Girshick Corporate Executive VP & COO | AGrant or award Common Stock | +4,057 | $0.00 | $0 | 54,569 | Feb 3, 2025 |
| Jan 31, 2025 | Flavia Pease Corporate Executive VP & CFO | AGrant or award Common Stock | +2,704 | $0.00 | $0 | 12,464 | Feb 3, 2025 |
| Jan 31, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | AGrant or award Common Stock | +2,738 | $0.00 | $0 | 25,259 | Feb 3, 2025 |
| Jan 31, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | AGrant or award Common Stock | +811 | $0.00 | $0 | 9,137 | Feb 3, 2025 |
| Jan 31, 2025 | Victoria L Creamer EVP & Chief People Officer | AGrant or award Common Stock | +2,468 | $0.00 | $0 | 17,297 | Feb 3, 2025 |
| Jan 31, 2025 | Victoria L Creamer EVP & Chief People Officer | FTax withholding Common Stock | -791 | $165.57 | $131k | 16,506 | Feb 3, 2025 |
| Jan 31, 2025 | Michael Gunnar Knell CSVP&Chief Accounting Officer | FTax withholding Common Stock | -282 | $165.57 | $47k | 8,855 | Feb 3, 2025 |
| Jan 31, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | AGrant or award Common Stock | +1,758 | $0.00 | $0 | 9,470 | Feb 3, 2025 |
| Jan 31, 2025 | Joseph W LaPlume EVP, Corp Strategy & Develop | FTax withholding Common Stock | -846 | $165.57 | $140k | 24,413 | Feb 3, 2025 |
| Jan 31, 2025 | Birgit Girshick Corporate Executive VP & COO | FTax withholding Common Stock | -1,025 | $165.57 | $170k | 53,544 | Feb 3, 2025 |
| Jan 31, 2025 | Flavia Pease Corporate Executive VP & CFO | FTax withholding Common Stock | -914 | $165.57 | $151k | 11,550 | Feb 3, 2025 |
| Jan 31, 2025 | Shannon M Parisotto CEVP, Disc & Safety Assessment | FTax withholding Common Stock | -471 | $165.57 | $78k | 8,999 | Feb 3, 2025 |
| Jan 31, 2025 | James C Foster Chairman, President and CEO | AGrant or award Common Stock | +19,608 | $0.00 | $0 | 204,391 | Feb 3, 2025 |
| Jan 31, 2025 | James C Foster Chairman, President and CEO | FTax withholding Common Stock | -6,827 | $165.57 | $1.1M | 197,564 | Feb 3, 2025 |
| Nov 6, 2024 | Richard F Wallman director | GGift Common Stock | -4,540 | $0.00 | $0 | 19,007 | Nov 12, 2024 |
| Nov 7, 2024 | Richard F Wallman director | SOpen-market sale Common Stock | -3,371 | $215.75 | $727k | 15,636 | Nov 12, 2024 |
| Nov 7, 2024 | Richard F Wallman director | SOpen-market sale Common Stock | -3,250 | $216.50 | $704k | 12,386 | Nov 12, 2024 |
| Nov 7, 2024 | Richard F Wallman director | SOpen-market sale Common Stockindirect: By Wife | -1,000 | $216.50 | $217k | 0 | Nov 12, 2024 |
| Nov 8, 2024 | James C Foster Chairman, President and CEO | GGift Common Stock | -4,500 | $0.00 | $0 | 184,783 | Nov 12, 2024 |
| Nov 7, 2024 | William D Barbo Corporate Executive VP & CCO | GGift Common Stockindirect: By Trust | -470 | $0.00 | $0 | 23,337 | Nov 8, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Nancy C Andrewsdirector
- William D BarboCorporate Executive VP & CCO
- Steven Bargdirector
- Abraham Ceesayceo, officer, director
- Glenn ColemanEVP & Chief Financial Officer
- Victoria L CreamerEVP & Chief People Officer
- Mark J Enyedydirector
- James C FosterChairman, President and CEO
- Birgit GirshickCorporate Executive VP & COO
- Paul W Gravesceo, president, officer, director
- Reshema Kemps-Polancodirector
- Michael Gunnar KnellCSVP&Chief Accounting Officer
- Joseph W LaPlumeEVP, Corp Strategy & Develop
- George Llado Sr.director
- Martin Mackaydirector
- George Massarodirector
- Shannon M ParisottoCEVP, Disc & Safety Assessment
- Flavia PeaseCorporate Executive VP & CFO
- Craig B. Thompsondirector
- Richard F Wallmandirector
- Virginia M Wilsondirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.